🏅 FDA Orphan Designation
Ukoniq
umbralisib
Manufacturer: TG Therapeutics, Inc.
Indicated for:📚 Splenic marginal zone lymphoma
Indications & Usage
treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen (Indication withdrawn) ||| Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy (Indication withdrawn) ||| Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen (Indication withdrawn)
💙 Support Programs
View all →Ukoniq
TG Therapeutics, Inc.
Ukoniq
TG Therapeutics, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.